Puma Biotechnology PBYI
NASDAQ PBYI
$8.08 -0.06 (-0.74%)
At close: Nov 11, 2026 · 4:00 PM EST

Puma Biotechnology (PBYI) Amortization of Deferred Charges (2012 - 2026)

Updated

Puma Biotechnology's Amortization of Deferred Charges came in at $3 million for FY2016, compared with $179,000 in FY2015.

Analysis

Puma Biotechnology (PBYI) Amortization of Deferred Charges (2012 - 2026) Analysis & Trends

  • Per Business Quant, earlier years put Amortization of Deferred Charges at $179,000 in FY2015 (-6.8%) and $192,000 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Puma Biotechnology 420.82 Mn 19.27 Mn 39.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 100,000.00
Dec 31, 2025 300,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 200,000.00
Dec 31, 2024 700,000.00
Sep 30, 2024 200,000.00
Jun 30, 2024 200,000.00
Dec 31, 2023 700,000.00
Sep 30, 2023 200,000.00
Jun 30, 2023 200,000.00
Mar 31, 2022 200,000.00
Mar 31, 2021 500,000.00
Mar 31, 2015 179,000.00
Dec 31, 2014 -711,000.00
Mar 31, 2014 903,000.00
Mar 31, 2013 903,000.00
Dec 31, 2012 227,000.00
Sep 30, 2012 675,954.00
Jun 30, 2012 675,954.00
API Access

Puma Biotechnology Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=PBYI&period=max&api_key=YOUR_API_KEY